Kita-kyushu lung cancer antigen 1, human

Clinical trials for Kita-kyushu lung cancer antigen 1, human explained in plain language.

Never miss a new study

Get alerted when new Kita-kyushu lung cancer antigen 1, human trials appear

Sign up with your email to follow new studies for Kita-kyushu lung cancer antigen 1, human, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental gene therapy targets common cancer protein

Disease control Stopped early

This early-phase trial tested a new type of immunotherapy for people with advanced cancers that carry a specific protein called KK-LC-1. The treatment involved collecting a patient's own immune cells, modifying them in the lab to better recognize and attack cancer cells, and infu…

Matched conditions: KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

Kita-kyushu lung cancer antigen 1, human

Get alerted when new Kita-kyushu lung cancer antigen 1, human trials appear

Experimental gene therapy targets common cancer protein